SWOT Analysis for Abbott India Ltd. - Threats

Add SWOT widget to your site/app

Companies with no Debt

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Expensive Performers (DVM)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Companies with high market cap, lower public shareholding

Bullish or Bearish Candlestick Strength - Indices

Expensive Performers (DVM)

Inverted Hammer (Bullish Reversal)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks